Ocular Therapeutix
OCUL
OCUL
69 hedge funds and large institutions have $86.4M invested in Ocular Therapeutix in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-4
Holders Change %
-5.48%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
26
Reduced
19
Closed
11
Calls
$565K
Puts
$416K
Net Calls
+$149K
Net Calls Change
-$474K
Top Buyers
| 1 |
SR
Summer Road
West Palm Beach,
Florida
|
+$3.01M |
| 2 |
Man Group
London,
United Kingdom
|
+$2.72M |
| 3 |
BlackRock
New York
|
+$1.99M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$635K |
Top Sellers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.5M |
| 2 |
Jennison Associates
New York
|
-$2.8M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.46M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.27M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.06M |
